Clementia Pharmaceuticals Inc.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jun 2015 | $60 M | No. 1 | $50 to $250 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Clementia Pharmaceuticals Inc. had no revenue when it filed its newest notice of a funding round (Jul 2015).
SEC Form D (revenue range) · Jul 2015
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Jul 2015
Products and services#
No products or services on record: its website did not answer.
Investors#
No investor of Clementia Pharmaceuticals Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 16 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Clarissa Desjardins | Executive officer | Jul 2015 |
| Donna Roy Grogan | Executive officer | Jul 2015 |
| Eric P. Grinstead | Executive officer | Jul 2015 |
| Jean-Francois P. Pariseau | Executive officer | Jul 2015 |
| Jeffrey Roy Packman | Executive officer | Jul 2015 |
| Michael Roy Singer | Executive officer | Jul 2015 |
| Allan P. Mandelzys | Director | Jul 2015 |
| Clarissa Desjardins | Director | Jul 2015 |
| David P. Bonita | Director | Jul 2015 |
| Francois P. Nader | Director | Jul 2015 |
| Jean-Francois P. Pariseau | Director | Jul 2015 |
| Robert P. Heft | Director | Jul 2015 |
About
Company in Paris, France.